Analyst Price Targets — CARA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 13, 2024 3:00 am | Sumant Kulkarni | Canaccord Genuity | $1.00 | $0.68 | StreetInsider | Canaccord Genuity Downgrades Cara Therapeutics (CARA) to Hold |
| June 12, 2024 5:47 pm | Annabel Samimy | Stifel Nicolaus | $1.00 | $0.68 | TheFly | Cara Therapeutics downgraded to Hold from Buy at Stifel |
| May 10, 2022 12:22 pm | Oren Livnat | H.C. Wainwright | $30.00 | $9.23 | TheFly | H.C. Wainwright sees 'major valuation disconnect' at Cara Therapeutics |
| March 3, 2022 12:00 am | Joseph Stringer | Needham | $26.00 | $11.08 | Pulse 2.0 | Cara Therapeutics (CARA) Stock: $26 Price Target And Buy Rating |
No recent news available for CARA.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CARA.
U.S. House Trading
No House trades found for CARA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.